Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma

PURPOSE: Mutations in the IDH1 and IDH2 (IDH1/2) genes occur in ~20% of intrahepatic cholangiocarcinoma (ICC) and lead to accumulation of 2-hydroxyglutarate (2HG) in the tumor tissue. However, it remains unknown whether IDH1/2 mutations can lead to high levels of 2HG circulating in the blood and whe...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Borger, Darrell R., Goyal, Lipika, Yau, Thomas, Poon, Ronnie T., Ancukiewicz, Marek, Deshpande, Vikram, Christiani, David C., Liebman, Hannah M., Yang, Hua, Kim, Hyeryun, Yen, Katharine, Faris, Jason E., Iafrate, A. John, Kwak, Eunice L., Clark, Jeffrey W., Allen, Jill N., Blaszkowsky, Lawrence S., Murphy, Janet E., Saha, Supriya K., Hong, Theodore S., Wo, Jennifer Y., Ferrone, Cristina R., Tanabe, Kenneth K., Bardeesy, Nabeel, Straley, Kimberly S., Agresta, Sam, Schenkein, David P., Ellisen, Leif W., Ryan, David P., Zhu, Andrew X.
التنسيق: Artigo
اللغة:Inglês
منشور في: 2014
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4107454/
https://ncbi.nlm.nih.gov/pubmed/24478380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-2649
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة